Literature DB >> 30555190

Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets.

Jason Abaluck1, Jonathan Gruber2, Ashley Swanson3.   

Abstract

Medicare Part D enrollees face a complicated decision: they dynamically choose prescription drug consumption in each period given difficult-to-find prices and a non-linear budget set. We use Part D claims data to estimate a flexible model of consumption that accounts for non-linear prices, dynamic responses, and salience. We use reduced form price responses from a linear regression of consumption on coverage range prices to compare performance under several models of behavior. We find small price elasticities, substantial myopia, and that salient characteristics impact consumption beyond their effect on prices. A hyperbolic discounting model with salience fits the data best.

Entities:  

Keywords:  Medicare; Moral hazard; nonlinear budget sets; prescription drugs; salience

Year:  2018        PMID: 30555190      PMCID: PMC6292523          DOI: 10.1016/j.jpubeco.2018.05.005

Source DB:  PubMed          Journal:  J Public Econ        ISSN: 0047-2727


  5 in total

1.  Bunching at the kink: implications for spending responses to health insurance contracts.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  J Public Econ       Date:  2016-11-26

2.  Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.

Authors:  Francesco Decarolis; Maria Polyakova; Stephen P Ryan
Journal:  J Polit Econ       Date:  2020-03-18

3.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

4.  Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.

Authors:  David Powell; Dana Goldman
Journal:  J Econom       Date:  2020-08-07       Impact factor: 2.388

5.  The Secret Menu in Health Care: A Cash Market for Imaging in California.

Authors:  Jordan Epstein; Sean Nicholson; Lucy Xiaolu Wang; Katherine Hempstead; Sam Asin
Journal:  Inquiry       Date:  2020 Jan-Dec       Impact factor: 1.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.